Anavex Life Sciences Corp - Company Profile

Powered by

All the sales intelligence you need on Anavex Life Sciences Corp in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Anavex Life Sciences Corp fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Anavex Life Sciences Corp.

Back to companies

Anavex Life Sciences Corp: Segment Analysis

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Business Description

Anavex Life Sciences Corp (Anavex) discovers and develops novel drugs for the treatment of diseases and disorders of the CNS and various types of cancer. The company's product pipeline targets indications for the treatment of Alzheimer’s disease, epilepsy, infantile spasms, Angelman syndrome, Rett syndrome, Fragile X syndrome, depression, neuropathic pain, new rare disease, malignant melanoma, prostate cancer and pancreatic cancer. The company operates through one reportable segment, namely, the development of novel therapies for the management of CNS diseases.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

R&D Overview

Anavex R&D efforts focus on the development of novel drugs for the treatment of diseases and disorders of CNS and various types of cancer. Anavex's key technology include Sigmaceptor discovery platform. The company major Pipeline products include ANAVEX 2-73 (Blarcamesine), ANAVEX 1-41, ANAVEX 3-71 (AF710B), and ANAVEX 1066.

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer